Cargando…
Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity
Protein-based vaccines offer a safer alternative to live-attenuated or inactivated vaccines but have limited immunogenicity. The identification of adjuvants that augment immunogenicity, specifically in a manner that is durable and antigen-specific, is therefore critical for advanced development. In...
Autores principales: | Martins, Karen A.O., Cooper, Christopher L., Stronsky, Sabrina M., Norris, Sarah L.W., Kwilas, Steven A., Steffens, Jesse T., Benko, Jacqueline G., van Tongeren, Sean A., Bavari, Sina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739439/ https://www.ncbi.nlm.nih.gov/pubmed/26870818 http://dx.doi.org/10.1016/j.ebiom.2015.11.041 |
Ejemplares similares
-
T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection
por: Cooper, Christopher L, et al.
Publicado: (2017) -
Quantitative Analysis of Repertoire-Scale Immunoglobulin Properties in Vaccine-Induced B-Cell Responses
por: Khavrutskii, Ilja V., et al.
Publicado: (2017) -
Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation
por: Martins, Karen A. O., et al.
Publicado: (2014) -
A thermostable, chromatographically purified Ebola nano-VLP vaccine
por: Carra, John H, et al.
Publicado: (2015) -
Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus
por: Warren, Travis K., et al.
Publicado: (2021)